Bio-Reference Laboratories, Inc. (NASDAQ:BRLI) has released the financial results for the three months period ended April 30, 2010. The company reported revenues of $110,447 for the quarter, showing a 27% increase over the year ago period. It’s operating income was $10,852, and net income after taxes was $5,787 for the quarter.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter
Bio-Reference’s six months revenues were also reported to have increased by 29% over the year ago period. Operating income for the six months period and fiscal year 2010 was $18,311 and net income after taxes was $9,792. The full financial report is available online for review at www.bioreference.com.
Bio-Reference Laboratories, Inc. (Bio-Reference) is principally engaged in providing laboratory testing services, primarily to customers in the greater New York metropolitan area, as well as to customers in a number of other states. The Company offers a list of chemical diagnostic tests, including blood and urine analysis, blood chemistry, hematology services, serology, radio-immuno analysis, toxicology (including drug screening), pap smears, tissue pathology (biopsies) and other tissue analysis. It operates two clinical laboratories, one in Elmwood Park, New Jersey and one in Valley Cottage, New York. The Company also operates an andrology laboratory in New York City; a cytogenetics testing laboratory located in Milford, Massachusetts; a pathology laboratory in Poughkeepsie, New York; a pathology laboratory in Clarksburg, Maryland, and a genetics laboratory in Gaithersburg, Maryland.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer
